Comparative Study of Low Doses of Rosuvastatin and Atorvastatin on Lipid and Glycemic Control in Patients with Metabolic Syndrome and Hypercholesterolemia
Jong-Seon Park, Young-Jo Kim, Ji-Yong Choi, Yoon-Nyun Kim, Teck-Jong Hong, Dong-Soo Kim, Ki-Young Kim, Myung-Ho Jeong, Jei-Keon Chae, Seok-Kyu Oh, In-Whan Seong
Korean J Intern Med. 2010;25(1):27-35.   Published online 2010 Feb 26     DOI: https://doi.org/10.3904/kjim.2010.25.1.27
Citations to this article as recorded by Crossref logo
Comparative effectiveness of statins in secondary prevention among the older people aged 75 years and over
Arim Kwak, Jae Hyun Kim, Cheol Ung Choi, In-Wha Kim, Jung Mi Oh, Kyungim Kim
International Journal of Clinical Pharmacy.2019; 41(2): 460.     CrossRef
2018 Guidelines for the management of dyslipidemia
Eun-Jung Rhee, Hyeon Chang Kim, Jae Hyeon Kim, Eun Young Lee, Byung Jin Kim, Eun Mi Kim, YoonJu Song, Jeong Hyun Lim, Hae Jin Kim, Seonghoon Choi, Min Kyong Moon, Jin Oh Na, Kwang-Yeol Park, Mi Sun Oh, Sang Youb Han, Junghyun Noh, Kyung Hee Yi, Sang-Hak L
The Korean Journal of Internal Medicine.2019; 34(4): 723.     CrossRef
2018 Guidelines for the Management of Dyslipidemia in Korea
Eun-Jung Rhee, Hyeon Chang Kim, Jae Hyeon Kim, Eun Young Lee, Byung Jin Kim, Eun Mi Kim, YoonJu Song, Jeong Hyun Lim, Hae Jin Kim, Seonghoon Choi, Min Kyong Moon, Jin Oh Na, Kwang-Yeol Park, Mi Sun Oh, Sang Youb Han, Junghyun Noh, Kyung Hee Yi, Sang-Hak L
Journal of Lipid and Atherosclerosis.2019; 8(2): 78.     CrossRef
Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol
L. Zhang, S. Zhang, Y. Yu, H. Jiang, J. Ge
Herz.2018;[Epub]     CrossRef
Effect of atorvastatin on serum omentin-1 in patients with coronary artery disease
Qianqian Chen, Xingchen Shang, Meng Yuan, Lining Liang, Xia Zhong
Coronary Artery Disease.2017; 28(1): 44.     CrossRef
Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis
Ziliang Ye, Haili Lu, Qiang Su, Wenqin Guo, Weiran Dai, Hongqing Li, Huafeng Yang, Lang Li, Dalin Tang
PLOS ONE.2017; 12(2): e0171682.     CrossRef
Effects of switching to low-dose rosuvastatin (5 mg/day) on glucose metabolism and lipid profiles in Japanese patients with type 2 diabetes and dyslipidemia: a single-arm, prospective, interventional trial
Akiko Kameda, Akinobu Nakamura, Yoshinobu Kondo, Mari Kimura, Yasuo Terauchi
Diabetology International.2017; 8(4): 383.     CrossRef
Economic Evaluation of Rosuvastatin and Atorvastatin for the Treatment of Dyslipidemia from a Korean Health System Perspective
Sunghwan Suh, Chang Hee Jung, Soon-Jun Hong, Jung-Sun Kim, Byung Ju Song, Hyun Soon Sohn, Sung Hee Choi
Journal of Lipid and Atherosclerosis.2016; 5(1): 61.     CrossRef
Open-label randomized non-inferiority trial of a fixed-dose combination of glimepiride and atorvastatin for the treatment of people whose Type 2 diabetes is uncontrolled on metformin
P. Ambery, A. Stylianou, G. Atkinson, C. Dott, L. Baylor Curtis, N. Haque, K. LaCroix, K. W. Min
Diabetic Medicine.2016; 33(8): 1084.     CrossRef
Safety of atorvastatin in Asian patients within clinical trials
Juliana C. N. Chan, Alice P. S. Kong, Weihang Bao, Rana Fayyad, Rachel Laskey
Cardiovascular Therapeutics.2016; 34(6): 431.     CrossRef
Atorvastatin for lowering lipids
Stephen P Adams, Michael Tsang, James M Wright
Cochrane Database of Systematic Reviews.2015;[Epub]     CrossRef
Cholesterol Lowering Effects of Low-dose Statins in Korean Patients
Jee Eun Kwon, Young Kim, Seonghyup Hyun, Hoyoun Won, Seung Yong Shin, Kwang Je Lee, Sang-Wook Kim, Tae Ho Kim, Chee Jeong Kim
Journal of Lipid and Atherosclerosis.2014; 3(1): 21.     CrossRef
Benefit–Risk Assessment of Rosuvastatin in the Treatment of Atherosclerosis and Related Diseases
Michael S. Kostapanos, Christos V. Rizos, Moses S. Elisaf
Drug Safety.2014; 37(7): 481.     CrossRef
Statin-Associated Incident Diabetes: A Literature Review
Zoon H. Park, Alicia Juska, Detelin Dyakov, Ramesh V. Patel
The Consultant Pharmacist.2014; 29(5): 317.     CrossRef
Rosuvastatin for lowering lipids
Stephen P Adams, Sarpreet S Sekhon, James M Wright
Cochrane Database of Systematic Reviews.2014;[Epub]     CrossRef
Atorvastatin improves erectile dysfunction in patients initially irresponsive to Sildenafil by the activation of endothelial nitric oxide synthase
A A El-Sisi, S K Hegazy, K A Salem, K S AbdElkawy
International Journal of Impotence Research.2013; 25(4): 143.     CrossRef
Rosuvastatin Does Not Affect Fasting Glucose, Insulin Resistance, or Adiponectin in Patients with Mild to Moderate Hypertension
Weon Kim, Myong Joo Hong, Jong Shin Woo, Won Yu Kang, Sun Ho Hwang, Wan Kim
Chonnam Medical Journal.2013; 49(1): 31.     CrossRef
A meta-analysis of randomized head-to-head trials of atorvastatin versus rosuvastatin for reductions in C-reactive protein
Hisato Takagi, Takuya Umemoto
International Journal of Cardiology.2012; 154(1): 78.     CrossRef
Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study
P. Anagnostis, D. Selalmatzidou, S. A. Polyzos, A. Panagiotou, A. Slavakis, A. Panagiotidou, V. G. Athyros, A. Karagiannis, D. P. Mikhailidis, M. Kita
International Journal of Clinical Practice.2011; 65(6): 679.     CrossRef
Comparison of Clinical Outcomes of Hydrophilic and Lipophilic Statins in Patients with Acute Myocardial Infarction
Min Chul Kim, Youngkeun Ahn, Su Young Jang, Kyung Hoon Cho, Seung Hwan Hwang, Min Goo Lee, Jum Suk Ko, Keun Ho Park, Doo Sun Sim, Nam Sik Yoon, Hyun Ju Yoon, Kye Hun Kim, Young Joon Hong, Hyung Wook Park, Ju Han Kim, Myung Ho Jeong, Jeong Gwan Cho, Jong C
The Korean Journal of Internal Medicine.2011; 26(3): 294.     CrossRef